Abstract:Background: A nationwide campaign for rational proton pump inhibitor (PPI) use launched in 2015 had a positive impact for hospitalized patients PPI use. But there were few studies focusing on the rational use of PPIs in outpatients. In 2018, the PPI management committee conducted a year-long intervention on the appropriate use of PPIs in outpatient and emergency departments, including clinical pharmacist interventions and stewardship interventions. The purpose of this study was to examine the impact of the PPI management committee's multifaceted interventions by comparing the real-world acid suppressant prescribing patterns for outpatients before (2017) and after intervention (2019) at a Chinese tertiary teaching hospital. Methods: Prescriptions containing any acid suppressant in outpatient and emergency departments in baseline (2017) and postintervention (2019) periods were extracted from the hospital information system and the prescription automatic screening system. Acid suppressant prescribing patterns were evaluated based on primary diagnoses and patient demographics. The prescribed acid suppressants stratified using age groups (< 7, 7-17, 18-45, 46-65, 66-85 and > 85 years) were also examined. Result: The utilization rate of acid suppressant in 2017 and 2019 was 2.5% (41,165/1,619,366) and 2.2% (49,550/2,236,471), respectively (P < 0.0001). 60,135 acid suppressant prescriptions were obtained in 2017 and 73,275 in 2019. The rate of acid suppressant prescriptions for the approved indications significantly increased from 62.6% (2017) to 65.4% (2019) (P < 0.0001). Prescriptions diagnosed as abnormal symptoms, signs and clinical manifestations, decreased in 2019 (13.0% vs. 16.5%, P < 0.0001). The most frequently prescribed PPIs differed between 2017 and 2019 (rabeprazole 2017 vs. esomeprazole 2019). Omeprazole was the most common PPI and cimetidine was the most common H2RA prescribed to patients aged < 18 years in 2017 and 2019. A total of CNY11.83 million was spent on acid suppressants in 2019, accounting for about 48.7% of total medication cost, increased by 11.3% from 2017 (37.4%). Conclusion: The proportion of acid suppressant prescriptions for approved indications was enhanced after the PPI management committee's multifaceted interventions, but there were still some problems in the selection of acid suppressants.

Retrospective Comments on Prescriptions of Oral Proton Pump Inhibitors for Outpatients in A General Hospital

Drug Utilization of Antihypertensives for Outpatients in a General Hospital

Clinical Application of Proton Pump Inhibitors

Effectiveness of Continuous Improvement by a Clinical Pharmacist-Led Guidance Team on the Prophylactic Antibiotics Usage Rationality in Intervention Procedure at a Chinese Tertiary Teaching Hospital

Rationale use of proton pump inhibitors: Observational study of hospital based prescriptions and role of clinical pharmacist

Analysis on The Use of Oral Proton Pump Inhibitors in The Inpatients of Peking University Shenzhen Hospital During 2009-2011

Optimization of Hospital Drug Management Model under the Supervision of Internet Plus Medical Health

Retrospective Analysis of Irrational Physician Orders for Discharged Patients

Analysis of the Irrational Drug Use of Intravenous Antineoplastic Agents

The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study

Impact of proton pump inhibitor management committee's multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments

Association of Proton Pump Inhibitor Prophylaxis on Clinical Outcome in Acute Ischemic Stroke in China: A Multicenter Retrospective Cohort Study.

Awareness, attitude and behavior regarding proton pump inhibitor among medical staff in the Southwest of China

Impact of Interventions Targeting the Inappropriate Use of Proton‐pump Inhibitors by Clinical Pharmacists in a Hepatobiliary Surgery Department

The appropriateness of a proton pump inhibitor prescription

Analysis of inappropriate prophylactic use of proton pump inhibitors during the perioperative period: an observational study

Prescribing practices for Proton pump inhibitors among primary care physicians in England

Proton Pump Inhibitors: Rational Use and Use-Reduction – The Windsor Workshop

Research Progress and Clinical Use of Proton Pump Inhibitors

Evidence-based evaluation of proton pump inhibitors off-label use

Comment on 17 077 Outpatient & Emergency Prescriptions and Analysis of Rational Drug Use